199
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Flaxseed Suppressed Prostatic Epithelial Proliferation in a Rat Model of Benign Prostatic Hyperplasia

, , &
Pages 453-465 | Received 08 Jul 2014, Accepted 27 Nov 2014, Published online: 18 Mar 2015

REFERENCES

  • Akamine, K., Koyama, T., and Yazawa, K. 2009. Banana peel extract suppressed prostate gland enlargement in testosterone-treated mice. Biosci. Biotechnol. Biochem. 73: 1911–1914.
  • Bergers, G., and Hanahan, D. 2008. Modes of resistance to anti-angiogenic therapy. Nat. Rev. Cancer 8: 592–603.
  • Bergman, J. M., Thompson, L. U., and Dabrosin, C. 2007. Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin. Cancer Res. 13: 1061–1067.
  • Bisson, J. F., Hidalgo, S., Simons, R., and Verbruggen, M. 2014. Preventive effects of lignan extract from flax hulls on experimentally induced benign prostate hyperplasia. J. Med. Food. Epub ahead of print. doi:10.1089.
  • Bosland, M. C., Chung, L. W. K., Greenberg, N. M., Ho, S. M., Isaacs, J. T., Lane, K., Peehl, D. M., Thompson, T. C., van Steenbrugge, G. J., and van Weerden, W. M. 1996. Recent advances in the development of animal and cell culture models for prostate cancer research. Urol. Oncol. 2: 99–128.
  • Bravi, F., Bosetti, C., Dal Maso, L., Talamini, R., Montella, M., Negri, E., Ramazzotti, V., Franceschi, S., and La Vecchia, C. 2006. Food groups and risk of benign prostatic hyperplasia. Urology 67: 73–79.
  • Brooks, J. D., and Thompson, L. U. 2005. Mammalian lignans and genistein decrease the activities of aromatase and 17 beta-hydroxysteroid dehydrogenase in MCF-7 cells. J. Steroid Biochem. Mol. Biol. 94: 461–467.
  • Ceylan, C., Serel, A., Doluoglu, O. G., Armağan, A., and Yuksel, S. 2013. Prostatic fluid free insulin-like growth factor-1 in relation to benign prostatic hyperplasia: A controlled study. Urol. J. 10: 1067–1071.
  • Chen, L. H., Fang, J., Li, H., Demark-Wahnefried, W., and Lin, X. 2007. Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway. Mol. Cancer Ther. 9: 2581–2590.
  • Chantreau, M., Grec, S., Gutierrez, L., Dalmais, M., Pineau, C., Demailly, H., Paysant-Leroux, C., Tavernier, R., Trouvé, J. P., Chatterjee, M., Guillot, X., Brunaud, V., Chabbert, B., van Wuytswinkel, O., Bendahmane, A., Thomasset, B., and Hawkins, S. 2013. PT-Flax (phenotyping and TILLinG of flax): Development of a flax (Linum usitatissimum L.) mutant population and TILLinG platform for forward and reverse genetics. BMC Plant Biol. 13: 159.
  • Davis, D. D., Ruiz, A. L., Yanes, L. L., Iliescu, R., Yuan, K., Moulana, M., Racusen, L. C., and Reckelhoff, J. F. 2012. Testosterone supplementation in male obese Zucker rats reduces body weight and improves insulin sensitivity but increases blood pressure. Hypertension 59: 726–731.
  • Demark-Wahnefried, W., Polascik, T. J., George, S. L., Switzer, B. R., Madden, J. F., Ruffin, M. T. 4th, Snyder, D. C., Owzar, K., Hars, V., Albala, D. M., Walther, P. J., Robertson, C. N., Moul, J. W., Dunn, B. K., Brenner, D., Minasian, L., Stella, P., and Vollmer, R. T. 2008. Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men pre-surgery. Cancer Epidemiol. Biomarkers Prev. 17: 3577–3587.
  • Demark-Wahnefried, W., Robertson, C. N., Walther, P. J., Polascik, T. J., Paulson, D. F., and Vollmer, R. T. 2004. Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen. Urology 63: 900–904.
  • Denis, L., Morton, M. S., and Griffiths, K. 1999. Diet and its preventive role in prostatic disease. Eur. Urol. 35: 377–387.
  • Dische, Z. 1957. Determination of pentoses. In Methods in enzymology, ed. S. P. Colourick and N. O. Kaplan, vol. III, 88. New York, NY: Academic Press.
  • Dische, Z., and Schwartz, K. 1954. Estimation of nucleic acids. In Methods of biochemical analysis, ed. D. Glick, vol. I, 299. New York, NY: Interscience.
  • Escobar, E. L. O., Gomes-Marcondes, M. C. C., and Carvalho, H. F. 2009. Dietary fatty acid quality affects AR and PPARγ levels and prostate growth. Prostate 69: 548–558.
  • Evans, B. A., Griffiths, K., and Morton, M. S. 1995. Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J. Endocrinol. 147: 295–302.
  • Fossati, P., and Prencipe, L. 1982. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin. Chem. 28: 2077–2080.
  • Freeman, V. L., Meydani, M., Hur, K., and Flanigan, R. C. 2004. Inverse association between prostatic polyunsaturated fatty acid and risk of locally advanced prostate carcinoma. Cancer 101: 2744–2754.
  • Hall, C. 3rd, Tulbek, M. C., and Xu, Y. 2006. Flaxseed. Adv. Food Nutr. Res. 51: 1–97.
  • Hardman, W. E. 2004. (n-3) Fatty acids and cancer therapy. J. Nutr. 134: 3427S–3430S.
  • Homma, Y., Kaneko, M., Kondo, Y., Kawabe, K., and Kakizoe, T. 1997. Inhibition of rat prostate carcinogenesis by a 5α-reductase inhibitor, FK143. J. Natl Cancer Inst. 89: 803–807.
  • Justulin, L. A., Jr., Acquaro, C., Carvalho, R. F., Dal Pai Silva, M., and Felisbino, S. L. 2010. Combined effect of the finasteride and doxazosin on rat ventral prostate morphology and physiology. Int. J. Androl. 33: 489–499.
  • Kang, K. K., Kim, J. M., Yu, J. Y., Ahn, B. O., Yoo, M., and Kim, Y. C. 2007. Effects of phosphodiesterase type 5 inhibitor on the contractility of prostate tissues and urethral pressure responses in a rat model of benign prostate hyperplasia. Int. J. Urol. 14: 946–951.
  • Kinniry, P., Amrani, Y., Vachani, A., Solomides, C. C., Arguiri, E., Workman, A., Carter, J., and Christofidou-Solomidou, M. 2006. Dietary flaxseed supplementation ameliorates inflammation and oxidative tissue damage in experimental models of acute lung injury in mice. J. Nutr. 136: 1545–1551.
  • Li, S. H., Ryu, J. H., Park, S. E., Cho, Y. S., Park, J. W., Lee, W. J., and Chun, Y. S. 2010. Vitamin C supplementation prevents testosterone-induced hyperplasia of rat prostate by down-regulating HIF-1α. J. Nutr. Biochem. 21: 801–808.
  • National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. Washington, DC: National Academies Press.
  • Neuhouser, M. L., Schenk, J., Song, Y. J., Tangen, C. M., Goodman, P. J., Pollak, M., Penson, D. F., Thompson, I. M., and Kristal, A. R. 2008. Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial. Prostate 68: 1477–1486.
  • Reeves, P. G., Nielsen, F. H., and Fahey, G. C., Jr. 1993. AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123: 1939–1951.
  • Rick, F. G., Schally, A. V., Block, N. L., Nadjic, M., Szepeshazi, K., Zarandi, M., Vidaurre, I., Perez, R., Halmos, G., and Szalontay, L. 2011a. Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia. Proc. Natl. Acad. Sci. USA 108: 3755–3760.
  • Rick, F. G., Schally, A. V., Block, N. L., Halmos, G., Perez, R., Fernandez, J. B., Vidaurre, I., and Szalontay, L. 2011b. LHRH Antagonist cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia. Prostate 71: 736–747.
  • Roberts, R. O., Jacobson, D. J., Girman, C. J., Rhodes, T., Klee, G. G., Lieber, M. M., and Jacobsen, S. J. 2003. Insulin-like growth factor 1, insulin-like growth factor binding protein 3, and urologic measures of benign prostatic hyperplasia. Am. J. Epidemiol. 167: 784–791.
  • Rohrmann, S., Giovannucci, E., Smit, E., and Platz, E. A. 2007. Association of IGF-1 and IGFBP-3 with lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey. Prostate 67: 1693–1698.
  • Saarinen, N. M., Tuominen, J., Pylkkänen, L., and Santti, R. 2010. Assessment of information to substantiate a health claim on the prevention of prostate cancer by lignans. Nutrients 2: 99–115.
  • Schneider, W. C. 1945. Phosphorus compounds in animal tissues. I. Extraction and estimation of desoxypentose nucleic acid and of pentose nucleic acid. J. Biol. Chem. 161: 293–303.
  • Scolnik, M. D., Servadio, C., and Abramovici, A. 1994. Comparative study of experimentally induced benign and atypical hyperplasia in the ventral prostate of different rat strains. J. Androl. 15: 287–297.
  • Shao, T. C., Kong, A., Marafelia, P., and Cunningham, G. R. 1993. Effects of finasteride on the rat ventral prostate. J. Androl. 14: 79–86.
  • Tarpila, A., Wennberg, T., and Tarpila, S. 2005. Flaxseed as a functional food. Curr. Top. Nutraceut. Res. 3: 167–188.
  • Tou, J. C. L., Chen, J., and Thompson, L. U. 1999. Dose, timing, and duration of flaxseed exposure affect reproductive indices and sex hormone levels in rats. J. Toxicol. Environ. Health A 56: 555–570.
  • Webb, A. L., and McCullough, M. L. 2005. Dietary lignans: Potential role in cancer prevention. Nutr. Cancer 51: 117–131.
  • Zhang, W., Wang, X., Liu, Y., Tian, H., Flickinger, B., Empie, M. W., and Sun, S. Z. 2008. Effects of dietary flaxseed lignan extract on symptoms of benign prostatic hyperplasia. J. Med. Food. 11: 207–214.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.